Combination of NK Cells and anti-PD-L1 Ab with ADCC enhances the anti-tumor effects in PD-L1 high cancer cells

被引：0
|
作者：
Park, Ji-Eun [1 ]
Keam, Bhumsuk [2 ]
Park, Ha-ram [1 ]
Kim, Soyeon [3 ]
Ock, Chan-Young [2 ]
Kim, Miso [2 ]
Kim, Tae Min [2 ]
Kim, Dong-Wan [2 ]
Heo, Dae Seog [2 ]
机构：
[1] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea
[2] Seoul Natl Univ Hosp, Seoul, South Korea
[3] SNUH, Biomed Res Inst, Seoul, South Korea
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P258
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Anti-PD-L1 DNA aptamer antagonizes the interaction of PD-1/PD-L1 with antitumor effect
    Gao, Tian
    Mao, Zheng
    Li, Wenjing
    Pei, Renjun
    JOURNAL OF MATERIALS CHEMISTRY B, 2021, 9 (03) : 746 - 756
  • [32] Dynamic changes of plasma PD-L1 mRNA expression is associated with anti-PD-1/anti-PD-L1 response in malignancies
    Yang, Q.
    Chen, M.
    Gu, J.
    Zheng, L.
    Yu, Y.
    Li, F.
    Zhang, L.
    Niu, K.
    Sun, J.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1777 - 1778
  • [33] Combination of ANTI-PD-1/ANTI-PD-L1 Antibodies With the Distinct Character Exerts Preferable Anti-Tumor Immune Cycle in a Murine Neuroblastoma Model
    Inoue, S.
    Horiuchi, Y.
    Setoyama, Y.
    Takeuchi, Y.
    Murakami, T.
    Odaka, A.
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S157 - S157
  • [34] Next generation of anti-PD-L1 Atezolizumab with enhanced anti-tumor efficacy in vivo
    Maohua Li
    Rongqing Zhao
    Jianxin Chen
    Wenzhi Tian
    Chenxi Xia
    Xudong Liu
    Yingzi Li
    Song Li
    Hunter Sun
    Tong Shen
    Wenlin Ren
    Le Sun
    Scientific Reports, 11
  • [35] Next generation of anti-PD-L1 Atezolizumab with enhanced anti-tumor efficacy in vivo
    Li, Maohua
    Zhao, Rongqing
    Chen, Jianxin
    Tian, Wenzhi
    Xia, Chenxi
    Liu, Xudong
    Li, Yingzi
    Li, Song
    Sun, Hunter
    Shen, Tong
    Ren, Wenlin
    Sun, Le
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [36] Building on the anti-PD1/PD-L1 backbone: combination immunotherapy for cancer
    Garces, Alvaro H. Ingles
    Au, Lewis
    Mason, Robert
    Thomas, Jennifer
    Larkin, James
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (08) : 695 - 708
  • [37] Critical role of PD-L1 expression on non-tumor cells rather than on tumor cells for effective anti-PD-L1 immunotherapy in a transplantable mouse hematopoietic tumor model
    Rodriguez-Barbosa, Jose-Ignacio
    Azuma, Miyuki
    Zelinskyy, Gennadiy
    Perez-Simon, Jose-Antonio
    del Rio, Maria-Luisa
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (06) : 1001 - 1014
  • [38] Critical role of PD-L1 expression on non-tumor cells rather than on tumor cells for effective anti-PD-L1 immunotherapy in a transplantable mouse hematopoietic tumor model
    Jose-Ignacio Rodriguez-Barbosa
    Miyuki Azuma
    Gennadiy Zelinskyy
    Jose-Antonio Perez-Simon
    Maria-Luisa del Rio
    Cancer Immunology, Immunotherapy, 2020, 69 : 1001 - 1014
  • [39] MLL3 enhances the transcription of PD-L1 and regulates anti-tumor immunity
    Xiong, Wei
    Deng, Huanghao
    Huang, Changkun
    Zen, Chong
    Jian, Chengzhu
    Ye, Kun
    Zhong, Zhaohui
    Zhao, Xiaokun
    Zhu, Liang
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2019, 1865 (02): : 454 - 463
  • [40] Dual Blockade of Lactate/GPR81 and PD-1/PD-L1 Pathways Enhances the Anti-Tumor Effects of Metformin
    Chen, Shaomeng
    Zhou, Xiuman
    Yang, Xin
    Li, Wanqiong
    Li, Shuzhen
    Hu, Zheng
    Ling, Chen
    Shi, Ranran
    Liu, Juan
    Chen, Guanyu
    Song, Nazi
    Jiang, Xianxing
    Sui, Xinghua
    Gao, Yanfeng
    BIOMOLECULES, 2021, 11 (09)
12345